Equities

F D C Ltd

F D C Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)568.95
  • Today's Change15.05 / 2.72%
  • Shares traded505.02k
  • 1 Year change+57.32%
  • Beta0.7045
Data delayed at least 15 minutes, as of Sep 20 2024 08:13 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments4,7544,8125,385
Total Receivables, Net1,6831,8711,228
Total Inventory4,0493,4623,285
Prepaid expenses1248985
Other current assets, total543618
Total current assets10,66510,26910,002
Property, plant & equipment, net9,3768,9298,052
Goodwill, net------
Intangibles, net424446
Long term investments3,9283,4853,847
Note receivable - long term626632676
Other long term assets285565
Total assets24,68123,42922,702
LIABILITIES
Accounts payable1,8601,7851,369
Accrued expenses537511462
Notes payable/short-term debt000
Current portion long-term debt/capital leases797569
Other current liabilities, total630744820
Total current liabilities3,1063,1162,722
Total long term debt126208253
Total debt205283322
Deferred income tax172111161
Minority interest0(6.44)(4.29)
Other liabilities, total3051813.26
Total liabilities3,7093,6093,134
SHAREHOLDERS EQUITY
Common stock163166169
Additional paid-in capital------
Retained earnings (accumulated deficit)20,68719,55219,300
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total12210299
Total equity20,97219,82019,568
Total liabilities & shareholders' equity24,68123,42922,702
Total common shares outstanding163166169
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.